CGM

The FDA has expanded its indication for Medtronic’s Guardian Sensor 3, allowing patients to wear the sensor on their upper arm.

Implantable glucose sensor company Senseonics has launched a remote monitoring app for its users in Europe, the Middle East, and Africa, where its CGM system is distributed by Roche.

Fitbit has recently invested $6 million in San Fransisco-based Sano, a company developing a mobile app and sensor that will allow users to continuously monitor blood glucose levels, multiple publications have confirmed.

Senseonics, a Germantown, Maryland-based company working on a longterm implantable continuous glucose monitor, has filed to go public with an IPO that, for now at least, is valued at $51.

When Kenneth Stack's son was diagnosed with Type 1 diabetes just before his fifth birthday, the doctor told Stack he was just a few years too early for a major medical breakthrough.

The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system.

The Dexcom G4 receiver Continuous glucose monitors are right now a good tool for a certain subset of people with diabetes, but there's still a majority of people, especially with Type 2 diabetes, for whom fingerstick glucometers are still the cheaper, more convenient option.

Medtronic has received FDA 510(k) clearance for its MiniMed Connect device, which allows users of Medtronic's continuous glucose monitor (CGM) and insulin pump to view data from those devices on their smartphone.

The Dexcom Follow Android App Diabetes management software company Glooko will add its first two continuous glucose monitor and pump integrations into its offering: Dexcom's G4 CGM and Insulet's OmniPod Insulin Management System.

Dexcom was one of the first companies to announce that it would have an Apple Watch app, and a recent FDA guideline made it clear that, as a secondary display device for a cleared CGM, the Apple Watch app wouldn't require its own clearance.